Toxocara canis in Australia

Invasive mammalian wildlife and the risk of zoonotic parasites

Invasive wild mammals are present in all continents, with Europe, North America, and the Asian-Pacific region having the largest number of established species. In particular, Europe has been the continent with the highest number of zoonotic parasites associated with invasive wild mammals. These invasive species may represent a major threat for the conservation of native ecosystems and may enter in the transmission cycle of native parasites, or act as spreaders of exotic parasites. Here, we review the role of invasive wild mammals as spreaders of zoonotic parasites, presenting important examples from Europe, America, and the Asia-Pacific region. Finally, we emphasize the need for more research on these mammals and their parasites, especially in areas where their monitoring is scantily performed.

Environmental Toxocara spp. presence in crowded squares and public parks from San Juan Province, Argentina: A call for a "One Health" approach

Introduction

Canine soil-transmitted helminth (cSTH) parasites need specific environmental conditions to complete their life cycle. Toxocara canis and T. cati are the most important zoonotic cSTH, since they are the causal agents of human toxocariasis. Canine STHs are dispersed in feces from infected domestic and wildlife canines. In this study, the presence of STH in canine feces was evaluated in 34 crowded public parks and squares from San Juan Province (Argentina).

Methods

Fecal samples were collected during different seasons in 2021-2022 and analyzed by standard coprological methods, including Sheather and Willis flotation and Telemann sedimentation. InfoStat 2020, OpenEpi V. 3.01 and R and RStudio® were used for statistical analysis and QGIS 3.16.10 for mapping.

Results

From a total of 1,121 samples collected, 100 (8.9%) were positive for at least one intestinal parasite (IP) and three cSTH species were detected: Toxocara spp., Toxascaris leonina and Trichuris vulpis. The most prevalent cSTH species was T. vulpis (64/1121; 0.057%), while the least prevalent was Toxocara spp. (19/1121; 0.017%). The detection of Toxocara spp. eggs was significantly different depending on the season. The geo-spatial variation of each cSTH per season is described.

Discussion

This is the first study in San Juan Province to identify environmental contamination of cSTHs in public areas. The specific localization of areas with the presence of cSTH eggs could provide information to guide strategies to reduce the cSTH infection burden in dogs and promote serological screening of the human population for Toxocara spp. Given the zoonotic nature of Toxocara spp. We hope this information will help to reinforce activities of control programs, focusing on the "One Health" approach.

Perceptions of dog owners towards canine gastrointestinal parasitism and associated human health risk in Southeast Queensland

Canine companion animals can carry a number of zoonotic parasites which can adversely impact both human and animal health. Previous studies in Australia indicated that while parasitic infections in dogs are still common and there is variability in the awareness and perception of zoonotic risks among pet owners, the likely contribution of sociodemographic factors to the variation in awareness and perception needs to be further explored. The primary objective of this study is to quantify the relationship between dog owners' knowledge and beliefs about dog parasites and their sociodemographic characteristics. In this study, we surveyed a total of 281 dog owners in SE Queensland between April 2019 to March 2020 and the relationship between dog owners' perception of gastrointestinal parasite infection was assessed using an adaptation of the Health Belief Model, social cognitive framework for health protection. The model looked into the role of dog owners' demography on their perceived severity and susceptibility to zoonotic canine parasites and their likelihood of performing actions associated with worm control of their pets. Our results indicate that owners perceptions about parasitic disease severity in their pets was 26% higher in female dog owners compared to males, in respondents owning dogs over 10 years (27% higher than those owning a dog <3 years) and those owners that regularly deworm their pets and report faeces disposal. Our study indicates that the perceptions of pet owners towards zoonotic canine parasites varies demographically and owner education is important to prevent infection among dogs and control the zoonotic transmission to owners and the community. Finally, there was evidence that increased frequency of visits to veterinary clinics can increase the likelihood of owners performing worm treatment, proper faecal disposal, and cooking meat before feeding it to dogs.

Efficacy of combination products containing sarolaner, moxidectin and pyrantel (Simparica Trio™) or afoxolaner and milbemycin (NexGard Spectra®) against induced infestations of Ixodes holocyclus in dogs

BACKGROUND

The Australian paralysis tick, Ixodes holocyclus, causes tick paralysis in dogs and cats in the eastern coastal regions of Australia. Prevention is the best option to protect dogs against this potentially fatal disease and sarolaner provides rapid and sustained efficacy against I. holocyclus. In this laboratory study, the efficacy of two combination endectocides containing sarolaner + moxidectin + pyrantel (Simparica Trio™) and afoxolaner + milbemycin (NexGard Spectra^®) was evaluated against an artificial infestation of I. holocyclus.

METHODS

Twenty-four (n =24) foxhounds were randomly allocated to three treatment groups and artificially infested with 30 adult female viable ticks on Days - 1, 7, 14, 21, 28 and 35. On Day 0, dogs in each treatment group were treated with either Drontal^® (control group), Simparica Trio™ at the label dose to provide minimum doses of sarolaner (1.2 mg/kg), moxidectin (24 µg/kg) and pyrantel (5 mg/kg) or NexGard Spectra^® to provide minimum doses of afoxolaner (2.5 mg/kg) and milbemycin (0.5 mg/kg). Live tick counts were performed at 48 and 72 hours after treatment and after each re-infestation on Days 7, 14, 21, 28 and 35. Efficacy was determined at each time point relative to counts for control dogs based on geometric means.

RESULTS

Against an existing infestation, efficacy of both Simparica Trio™ and NexGard Spectra^® was 99.6% and 100% at 48 and 72 h time points, respectively (P = 1.000). Against subsequent weekly infestations, treatment with Simparica Trio™ and NexGard Spectra^® resulted in efficacy of ≥ 97.7% and ≥ 95.5% (P ≥ 0.0911), respectively at the 48 h time point and at the 72 h time point, Simparica Trio™ and NexGard Spectra^® resulted in efficacy of ≥ 99.0% and ≥ 98.4% (P ≥ 0.0511), respectively. There were no treatment-related adverse events in the study.

CONCLUSIONS

Single doses of Simparica Trio™ and NexGard Spectra^® were highly efficacious and provided comparable efficacy against the Australian paralysis tick, I. holocyclus for up to 35 days.